Terbinafine-induced hepatic failure requiring liver transplantation

Zeeshan Perveze, Mark W. Johnson, Raymond A. Rubin, Marty Sellers, Carlos F Zayas Montalvo, Jody L. Jones, Rosemary Cross, Kimberly Thomas, Bradley Butler, Roshan Shrestha

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Drug-induced liver disease accounts for about 50% of acute or subacute liver failure in the United States. United Network of Organ Sharing (UNOS) data suggest 8%-20% of liver transplantation in this country per year is for fulminant liver failure due to drugs. Even though the most common medication implicated in acute liver injury is acetaminophen (75%), there are numerous other drugs that are responsible for acute and chronic liver injury. A variety of antifungal medications are known to cause a wide range of liver injury from a mild hepatocellular-cholestatic injury pattern to acute/subacute liver failure. Terbinafine is one of the antifungals that have been associated with such liver injuries. We report a case of terbinafine-induced severe liver failure requiring liver transplantation.

Original languageEnglish (US)
Pages (from-to)162-164
Number of pages3
JournalLiver Transplantation
Volume13
Issue number1
DOIs
StatePublished - Jan 22 2007

Fingerprint

terbinafine
Liver Failure
Liver Transplantation
Wounds and Injuries
Acute Liver Failure
Liver
Chemical and Drug Induced Liver Injury
Information Dissemination
Acetaminophen
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Cite this

Perveze, Z., Johnson, M. W., Rubin, R. A., Sellers, M., Zayas Montalvo, C. F., Jones, J. L., ... Shrestha, R. (2007). Terbinafine-induced hepatic failure requiring liver transplantation. Liver Transplantation, 13(1), 162-164. https://doi.org/10.1002/lt.21034

Terbinafine-induced hepatic failure requiring liver transplantation. / Perveze, Zeeshan; Johnson, Mark W.; Rubin, Raymond A.; Sellers, Marty; Zayas Montalvo, Carlos F; Jones, Jody L.; Cross, Rosemary; Thomas, Kimberly; Butler, Bradley; Shrestha, Roshan.

In: Liver Transplantation, Vol. 13, No. 1, 22.01.2007, p. 162-164.

Research output: Contribution to journalArticle

Perveze, Z, Johnson, MW, Rubin, RA, Sellers, M, Zayas Montalvo, CF, Jones, JL, Cross, R, Thomas, K, Butler, B & Shrestha, R 2007, 'Terbinafine-induced hepatic failure requiring liver transplantation', Liver Transplantation, vol. 13, no. 1, pp. 162-164. https://doi.org/10.1002/lt.21034
Perveze, Zeeshan ; Johnson, Mark W. ; Rubin, Raymond A. ; Sellers, Marty ; Zayas Montalvo, Carlos F ; Jones, Jody L. ; Cross, Rosemary ; Thomas, Kimberly ; Butler, Bradley ; Shrestha, Roshan. / Terbinafine-induced hepatic failure requiring liver transplantation. In: Liver Transplantation. 2007 ; Vol. 13, No. 1. pp. 162-164.
@article{ee2dd356fd5a40c9857ded09b224c275,
title = "Terbinafine-induced hepatic failure requiring liver transplantation",
abstract = "Drug-induced liver disease accounts for about 50{\%} of acute or subacute liver failure in the United States. United Network of Organ Sharing (UNOS) data suggest 8{\%}-20{\%} of liver transplantation in this country per year is for fulminant liver failure due to drugs. Even though the most common medication implicated in acute liver injury is acetaminophen (75{\%}), there are numerous other drugs that are responsible for acute and chronic liver injury. A variety of antifungal medications are known to cause a wide range of liver injury from a mild hepatocellular-cholestatic injury pattern to acute/subacute liver failure. Terbinafine is one of the antifungals that have been associated with such liver injuries. We report a case of terbinafine-induced severe liver failure requiring liver transplantation.",
author = "Zeeshan Perveze and Johnson, {Mark W.} and Rubin, {Raymond A.} and Marty Sellers and {Zayas Montalvo}, {Carlos F} and Jones, {Jody L.} and Rosemary Cross and Kimberly Thomas and Bradley Butler and Roshan Shrestha",
year = "2007",
month = "1",
day = "22",
doi = "10.1002/lt.21034",
language = "English (US)",
volume = "13",
pages = "162--164",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Terbinafine-induced hepatic failure requiring liver transplantation

AU - Perveze, Zeeshan

AU - Johnson, Mark W.

AU - Rubin, Raymond A.

AU - Sellers, Marty

AU - Zayas Montalvo, Carlos F

AU - Jones, Jody L.

AU - Cross, Rosemary

AU - Thomas, Kimberly

AU - Butler, Bradley

AU - Shrestha, Roshan

PY - 2007/1/22

Y1 - 2007/1/22

N2 - Drug-induced liver disease accounts for about 50% of acute or subacute liver failure in the United States. United Network of Organ Sharing (UNOS) data suggest 8%-20% of liver transplantation in this country per year is for fulminant liver failure due to drugs. Even though the most common medication implicated in acute liver injury is acetaminophen (75%), there are numerous other drugs that are responsible for acute and chronic liver injury. A variety of antifungal medications are known to cause a wide range of liver injury from a mild hepatocellular-cholestatic injury pattern to acute/subacute liver failure. Terbinafine is one of the antifungals that have been associated with such liver injuries. We report a case of terbinafine-induced severe liver failure requiring liver transplantation.

AB - Drug-induced liver disease accounts for about 50% of acute or subacute liver failure in the United States. United Network of Organ Sharing (UNOS) data suggest 8%-20% of liver transplantation in this country per year is for fulminant liver failure due to drugs. Even though the most common medication implicated in acute liver injury is acetaminophen (75%), there are numerous other drugs that are responsible for acute and chronic liver injury. A variety of antifungal medications are known to cause a wide range of liver injury from a mild hepatocellular-cholestatic injury pattern to acute/subacute liver failure. Terbinafine is one of the antifungals that have been associated with such liver injuries. We report a case of terbinafine-induced severe liver failure requiring liver transplantation.

UR - http://www.scopus.com/inward/record.url?scp=33846192798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846192798&partnerID=8YFLogxK

U2 - 10.1002/lt.21034

DO - 10.1002/lt.21034

M3 - Article

VL - 13

SP - 162

EP - 164

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 1

ER -